Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
43,817,541
-
Share change
-
+8,305,955
-
Total reported value
-
$1,396,888,696
-
Put/Call ratio
-
66%
-
Price per share
-
$31.88
-
Number of holders
-
96
-
Value change
-
+$262,074,543
-
Number of buys
-
61
-
Number of sells
-
38
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2016
As of 31 Dec 2016 Theravance Biopharma, Inc. - Common Stock (TBPH) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,817,541 shares of stock of the company.
Largest 10 holders included Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, FIRST MANHATTAN CO, Cormorant Asset Management, LLC, BlackRock Institutional Trust Company, N.A., NORGES BANK, and STATE STREET CORP.
This table shows 96 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.